Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2008-02-141382PMID 18509086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment

  2008cited by this paper
• Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

  2008cited by this paper
• MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L)

  2007cited by this paper
• Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation

  2007cited by this paper
• Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia

  2007cited by this paper
• Life and death in peripheral T cells

  2007cited by this paper
• Linking calcineurin activity to leukemogenesis

  2007cited by this paper
• An Emerging Role for Ca2+/Calcineurin/NFAT Signaling in Cancerogenesis

  2007cited by this paper
• MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

  2007cited by this paper
• E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort

  2006cited by this paper
• Cyclosporin A Abolishes CD28-Mediated Resistance to CD95-Induced Apoptosis via Superinduction of Caspase-31

  2006cited by this paper
• The c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation

  2006cited by this paper
• Cellular FLIP Long Form Augments Caspase Activity and Death of T Cells through Heterodimerization with and Activation of Caspase-81

  2005cited by this paper
• Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail*

  2005cited by this paper
• Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes

  2005cited by this paper
• NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

  2005cited by this paper
• The caspase-8 modulator c-FLIP.

  2005cited by this paper
• c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis*

  2005cited by this paper
• The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.

  2005cited by this paper
• MatInspector and beyond: promoter analysis based on transcription factor binding sites

  2005cited by this paper
• Rocaglamide Derivatives Are Immunosuppressive Phytochemicals That Target NF-AT Activity in T Cells

  2005cited by this paper
• NFAT proteins: key regulators of T-cell development and function

  2005cited by this paper
• NF-κB–regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor α–mediated apoptosis

  2004cited by this paper
• Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition

  2004cited by this paper
• Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity

  2004cited by this paper
• NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.

  2004cited by this paper
• The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP*

  2004cited by this paper
• Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort1

  2004cited by this paper
• A new cell-permeable peptide allows successful allogeneic islet transplantation in mice

  2004cited by this paper
• Lymphocyte-mediated cytotoxicity.

  2003cited by this paper
• An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death 1

  2003cited by this paper
• Antiapoptotic function of NF-κB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL

  2003cited by this paper
• Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.

  2002cited by this paper
• c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis

  2002cited by this paper
• Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells*

  2002cited by this paper
• Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis.

  2002cited by this paper
• The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex*

  2002cited by this paper
• p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells

  2001cited by this paper
• NF-κB Signals Induce the Expression of c-FLIP

  2001cited by this paper
• NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling

  2001cited by this paper
• Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex*

  2001cited by this paper
• Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells

  2001cited by this paper
• Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.

  2001cited by this paper
• Sequential involvement of NFAT and Egr transcription factors in FasL regulation.

  2000cited by this paper
• Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis.

  2000cited by this paper
• Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development.

  2000cited by this paper
• TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity1

  2000cited by this paper
• The Role of c-FLIP in Modulation of CD95-induced Apoptosis*

  1999cited by this paper
• A regulatory element in the CD95 (APO‐1/Fas) ligand promoter is essential for responsiveness to TCR‐mediated activation

  1998cited by this paper
• Mitogen-activated Protein Kinase Kinase Antagonized Fas-associated Death Domain Protein–mediated Apoptosis by Induced FLICE-inhibitory Protein Expression

  1998cited by this paper
• Transcription: activation by cooperating conformations.

  1998cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• Two NFAT Transcription Factor Binding Sites Participate in the Regulation of CD95 (Fas) Ligand Expression in Activated Human T Cells*

  1997cited by this paper
• CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

  1995cited by this paper
• Activation interferes with the APO-1 pathway in mature human T cells.

  1993cited by this paper
• Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

  1992cited by this paper
• Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

  1991cited by this paper

• Fish requires FasL to facilitate CD8+ T-cell function and antimicrobial immunity.

  2025cites this paper
• MultiSC: a deep learning pipeline for analyzing multiomics single-cell data

  2024cites this paper
• Triptolide-mediated downregulation of FLIPS in hepatoma cells occurs at the post-transcriptional level independently of proteasome-mediated pathways

  2022cites this paper
• The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function

  2021cites this paper
• Bclaf1 regulates c‐FLIP expression and protects cells from TNF‐induced apoptosis and tissue injury

  2021cites this paper
• Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks.

  2021cites this paper
• NFATC2 Modulates Radiation Sensitivity in Dermal Fibroblasts From Patients With Severe Side Effects of Radiotherapy

  2020cites this paper
• c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice

  2020cites this paper
• c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma

  2019cites this paper
• Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP

  2019cites this paper
• Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity

  2019cites this paper
• Surveillance of Myelodysplastic Syndrome via Migration Analyses of Blood Neutrophils: A Potential Prognostic Tool

  2018cites this paper
• EOMES‐positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers

  2018cites this paper
• FLIP as a therapeutic target in cancer

  2018cites this paper
• Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy

  2017cites this paper
• Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression

  2017cites this paper
• c-FLIP Expression in Foxp3-Expressing Cells Is Essential for Survival of Regulatory T Cells and Prevention of Autoimmunity.

  2017cites this paper
• Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player

  2016influential citation
• Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain

  2015cites this paper
• DED or alive: assembly and regulation of the death effector domain complexes

  2015cites this paper
• B Cells Producing Pathogenic Autoantibodies

  2015cites this paper
• The Regulation and Role of c-FLIP in Human Th Cell Differentiation

  2014cites this paper
• Chemistry and Biology of Rocaglamides (= Flavaglines) and Related Derivatives from Aglaia Species (Meliaceae)

  2014cites this paper
• Regulation of lymphocyte response in vitro and in vivo

  2013cites this paper
• Targeting c-FLIP in cancer.

  2013cites this paper
• Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer

  2013cites this paper
• FLIP: a flop for execution signals.

  2013cites this paper
• Mathematical modeling of apoptosis

  2013cites this paper
• Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling

  2013cites this paper
• Cellular‐FLIP, Raji isoform (c‐FLIPR) modulates cell death induction upon T‐cell activation and infection

  2013cites this paper
• Molecular mechanisms of anti-proliferative effects of the Traditional Chinese Medicinal compound Rocaglamide A on cancers

  2012influential citation
• Systems Biology of Death Receptor-Induced Apoptosis

  2012cites this paper
• NFATc1/αA: The other Face of NFAT Factors in Lymphocytes

  2012cites this paper
• Evidence-based Anticancer Materia Medica for Leukemia

  2012cites this paper
• Nuclear factor of activated T cells (NFAT) signaling regulates PTEN expression and intestinal cell differentiation

  2011cites this paper
• Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).

  2011cites this paper
• Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression

  2011cites this paper
• The role of c-FLIP splice variants in urothelial tumours

  2011cites this paper
• Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy

  2011cites this paper
• Siglec-G Regulates B1 Cell Survival and Selection

  2010cites this paper
• Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression

  2009influential citation
• Anticancer Activity and Differentially Expressed Genes in Head and Neck Cancer Cells Treated with a Novel Cyclin-Dependent Kinase Inhibitor

  2009cites this paper
• Defective Survival of Naive CD8+ T Lymphocytes in the absence of β3 regulatory subunit of Cav channels

  2009cites this paper
• Death receptor signal transducers: nodes of coordination in immune signaling networks

  2009cites this paper
• Activation-induced Degradation of FLIPL Is Mediated via the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Macrophages*

  2009cites this paper
• Impaired CD95-mediated Apoptosis in Autoimmunity and Occurrence of a p22 Caspase-8 Cleavage Product in JIA

  2008cites this paper